Comparative study of fresh and cryopreserved rat mesenchymal stem cells: cell viability, immunological gene expression, and cytokine production
DOI:
https://doi.org/10.31210/spi2026.29.02.27Keywords:
mesenchymal stem cells (MSCs), cryopreservation, cell viability, immunomodulatory gene expression, cytokine secretion profile, paracrine trophic activityAbstract
Cryopreservation is fundamental for mesenchymal stem cell (MSC) banking, but the freeze–thaw cycle induces sub-cellular stress, potentially modifying the post-thaw genomic and paracrine identity of the cellular product. This study aimed to compare the biological, molecular, and functional stability of fresh and cryopreserved rat bone marrow MSCs (Rattus norvegicus BM-MSCs). Rat BM-MSCs were allocated into non-cryopreserved control cells (Fresh-MSCs) and cells frozen for 4 weeks in liquid nitrogen using 10 % DMSO (Cryo-MSCs). Cell survival was determined using the MTT assay. Immunoregulatory (Il10, Tgfβ1, Ido1) and apoptotic (Bax, Casp3, Bcl2) transcripts were evaluated via RT-qPCR. Paracrine protein concentrations of IL-10, TGF-β, TNF-α, IL-6, VEGF, and HGF were quantified via ELISA. Cryogenic processing significantly reduced post-thaw cell survival relative to fresh controls, though cellular viability safely remained high (87.32±2.91 % vs. 100.00±3.67 %; P<0.001). At the transcriptomic tier, Cryo-MSCs displayed a profound downregulation of all key immunomodulatory transcripts (P<0.05), with Il10, Tgfβ1, and Ido1 levels dropping to 0.68±0.07, 0.77±0.06, and 0.61±0.06, respectively. This matched a 21.58 % and 21.87 % drop in secreted IL-10 and TGF-β protein concentrations (P≤0.05), running parallel to a 15 % to 20 % loss in the paracrine release of VEGF and HGF (P≤0.01). Conversely, cryogenic shock triggered an acute stress response that severely inverted the mitochondrial apoptosis ratio, inducing a significant 1.61-fold upsurge in pro-apoptotic Bax and a 1.49-fold increase in executioner Casp3 transcripts, coupled with a 30.0 % reduction in survival-associated Bcl2 mRNA (P≤0.05). This transcriptomic disruption reprogrammed the post-thaw secretome toward an inflammatory phenotype, characterized by a dramatic 2.12-fold and 1.59-fold escalation in secreted TNF-α and IL-6 protein levels, respectively (P≤0.05). Standard cryopreservation effectively preserves cell viability but causes a temporary operational impairment encompassing transcriptomic suppression of immunomodulatory networks, downregulatory trophic trends, and accelerated apoptotic signaling. These findings reveal compromised functional quality post-thaw, highlighting the clinical necessity for an optimized post-thaw acclimation incubation period prior to cell administration.
References
1. Law, S., & Chaudhuri, S. (2013). Mesenchymal stem cell and regenerative medicine: regeneration versus immunomodulatory challenges. American Journal of Stem Cells, 2(1), 22–38.
2. Han, X., Liao, R., Li, X., Zhang, C., Huo, S., Qin, L., Xiong, Y., He, T., Xiao, G., & Zhang, T. (2025). Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies. Signal Transduction and Targeted Therapy, 10(1), 262. https://doi.org/10.1038/s41392-025-02313-9
3. Esmael, G. K., Rebai, T., & Al-Nailey, K. G. C. (2023). Immunomodulatory effects of bone marrow-derived mesenchymal stem cells on BALB/c mice model with induced systemic lupus erythematosus (SLE): effects of bone marrow-derived mesenchymal stem cells. Cellular and Molecular Biology, 69(1), 19–24. https://doi.org/10.14715/cmb/2022.69.1.4
4. Song, N., Scholtemeijer, M., & Shah, K. (2020). Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential. Trends in Pharmacological Sciences, 41(9), 653–664. https://doi.org/10.1016/j.tips.2020.06.009
5. Wang, J., & Li, R. (2024). Correction: Effects, methods and limits of the cryopreservation on mesenchymal stem cells. Stem Cell Research & Therapy, 15(1), 372. https://doi.org/10.1186/s13287-024-04001-x
6. Wang, Y., Yang, K., Yuan, S., Huo, F., Yang, C., & Tian, W. (2026). Research advances in cryopreserved preparations of mesenchymal stem cells: technical innovations, application challenges, and quality control. Frontiers in Bioengineering and Biotechnology, 14, 1717539. https://doi.org/10.3389/fbioe.2026.1717539
7. Antebi, B., Asher, A. M., Rodriguez, L. A., Moore, R. K., Mohammadipoor, A., & Cancio, L. C. (2019). Cryopreserved mesenchymal stem cells regain functional potency following a 24-h acclimation period. Journal of Translational Medicine, 17(1), 297. https://doi.org/10.1186/s12967-019-2038-5
8. Tan, Y., Salkhordeh, M., Wang, J.-P., McRae, A., Souza-Moreira, L., McIntyre, L., Stewart, D. J., & Mei, S. H. J. (2019). Thawed mesenchymal stem cell product shows comparable immunomodulatory potency to cultured cells in vitro and in polymicrobial septic animals. Scientific Reports, 9(1), 18078. https://doi.org/10.1038/s41598-019-54462-x
9. Clarke, D. M., Yadock, D. J., Nicoud, I. B., Mathew, A. J., & Heimfeld, S. (2009). Improved post-thaw recovery of peripheral blood stem/progenitor cells using a novel intracellular-like cryopreservation solution. Cytotherapy, 11(4), 472–479. https://doi.org/10.1080/14653240902887242
10. Bahsoun, S., Coopman, K., & Akam, E. C. (2020). Quantitative assessment of the impact of cryopreservation on human bone marrow-derived mesenchymal stem cells: up to 24 h post-thaw and beyond. Stem Cell Research & Therapy, 11(1), 540. https://doi.org/10.1186/s13287-020-02054-2
11. Ray, S. S., Pramanik, K., Sarangi, S. K., & Jain, N. (2016). Serum-free non-toxic freezing solution for cryopreservation of human adipose tissue-derived mesenchymal stem cells. Biotechnology Letters, 38(8), 1397–1404. https://doi.org/10.1007/s10529-016-2111-6
12. Mamo, T., Cox, C. A., Demorest, C., Fontaine, M. J., Hubel, A., Kelley, L., Khan, A., Marks, D. C., Pati, S., Reems, J.-A., Spohn, G., Schäfer, R., Shi, R., Shao, L., Stroncek, D., & McKenna, D. H. (2024). Cryopreservation of mesenchymal stem/stromal cells using a DMSO-free solution is comparable to DMSO-containing cryoprotectants: results of an international multicenter PACT/BEST collaborative study. Cytotherapy, 26(12), 1522–1531. https://doi.org/10.1016/j.jcyt.2024.07.001
13. Putra, I., Shen, X., Anwar, K. N., Rabiee, B., Samaeekia, R., Almazyad, E., Giri, P., Jabbehdari, S., Hayat, M. R., Elhusseiny, A. M., Ghassemi, M., Mahmud, N., Edward, D. P., Joslin, C. E., Rosenblatt, M. I., Dana, R., Eslani, M., Hematti, P., & Djalilian, A. R. (2021). Preclinical evaluation of the safety and efficacy of cryopreserved bone marrow mesenchymal stromal cells for corneal repair. Translational Vision Science & Technology, 10(10), 3. https://doi.org/10.1167/tvst.10.10.3
14. Shah, F. S., Li, J., Zanata, F., Curley, J. L., Martin, E. C., Wu, X., Dietrich, M., Devireddy, R. V., Wade, J. W., & Gimble, J. M. (2016). The relative functionality of freshly isolated and cryopreserved human adipose-derived stromal/stem cells. Cells Tissues Organs, 201(6), 436–444. https://doi.org/10.1159/000446494
15. Xu, X., Liu, Y., Cui, Z., Wei, Y., & Zhang, L. (2012). Effects of osmotic and cold shock on adherent human mesenchymal stem cells during cryopreservation. Journal of Biotechnology, 162(2-3), 224–231. https://doi.org/10.1016/j.jbiotec.2012.09.004
16. Shivakumar, S. B., Bharti, D., Jang, S.-J., Hwang, S.-C., Park, J.-K., Shin, J.-K., Byun, J.-H., Park, B.-W., & Rho, G.-J. (2015). Cryopreservation of human Wharton’s jelly-derived mesenchymal stem cells following controlled rate freezing protocol using different cryoprotectants; a comparative study. International Journal of Stem Cells, 8(2), 155–169. https://doi.org/10.15283/ijsc.2015.8.2.155
17. Ryan, J. M., Barry, F., Murphy, J. M., & Mahon, B. P. (2007). Interferon-γ does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clinical and Experimental Immunology, 149(2), 353–363. https://doi.org/10.1111/j.1365-2249.2007.03422.x
18. Holan, V., Hermankova, B., Bohacova, P., Kossl, J., Chudickova, M., Hajkova, M., Krulova, M., Zajicova, A., & Javorkova, E. (2016). Distinct immunoregulatory mechanisms in mesenchymal stem cells: role of the cytokine environment. Stem Cell Reviews and Reports, 12(6), 654–663. https://doi.org/10.1007/s12015-016-9688-y
19. François, M., Copland, I. B., Yuan, S., Romieu-Mourez, R., Waller, E. K., & Galipeau, J. (2012). Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing. Cytotherapy, 14(2), 147–152. https://doi.org/10.3109/14653249.2011.623691
20. Moll, G., Alm, J. J., Davies, L. C., von Bahr, L., Heldring, N., Stenbeck-Funke, L., Hamad, O. A., Hinsch, R., Ignatowicz, L., Locke, M., Lönnies, H., Lambris, J. D., Teramura, Y., Nilsson-Ekdahl, K., Nilsson, B., & Le Blanc, K. (2014). Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties? Stem Cells, 32(9), 2430–2442. https://doi.org/10.1002/stem.1729
21. Nasef, A., Chapel, A., Mazurier, C., Bouchet, S., Lopez, M., Mathieu, N., Sensebé, L., Zhang, Y., Gorin, N.-C., Thierry, D., & Fouillard, L. (2006). Identification of IL-10 and TGF-β transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells. Gene Expression, 13(4), 217–226. https://doi.org/10.3727/000000006780666957
22. Zhao, Z.-G., Li, W.-M., Chen, Z.-C., You, Y., & Zou, P. (2008). Hematopoiesis capacity, immunomodulatory effect and ex vivo expansion potential of mesenchymal stem cells are not impaired by cryopreservation. Cancer Investigation, 26(4), 391–400. https://doi.org/10.1080/07357900701788049
23. Bissoyi, A., & Pramanik, K. (2014). Role of the apoptosis pathway in cryopreservation-induced cell death in mesenchymal stem cells derived from umbilical cord blood. Biopreservation and Biobanking, 12(4), 246–254. https://doi.org/10.1089/bio.2014.0005
24. Moll, G., Geißler, S., Catar, R., Ignatowicz, L., Hoogduijn, M. J., Strunk, D., Bieback, K., & Ringdén, O. (2016). Cryopreserved or fresh mesenchymal stromal cells: only a matter of taste or key to unleash the full clinical potential of MSC therapy? In K. Bieback, D. Strunk, & G. Geißler (Eds.), Mesenchymal stromal cells: analytical and technical advancements (pp. 77–98). Springer. https://doi.org/10.1007/978-3-319-45457-3_7
25. Aabling, R. R., Alstrup, T., Kjær, E. M., Poulsen, K. J., Pedersen, J. O., Revenfeld, A. L., Møller, B. K., & Eijken, M. (2023). Reconstitution and post-thaw storage of cryopreserved human mesenchymal stromal cells: Pitfalls and optimizations for clinically compatible formulants. Regenerative Therapy, 23, 67–75. https://doi.org/10.1016/j.reth.2023.03.006
26. Linkova, D. D., Rubtsova, Y. P., & Egorikhina, M. N. (2022). Cryostorage of mesenchymal stem cells and biomedical cell-based products. Cells, 11(17), 2691. https://doi.org/10.3390/cells11172691
27. Li, W., Liu, Q., Shi, J., Xu, X., & Xu, J. (2023). The role of TNF-α in the fate regulation and functional reprogramming of mesenchymal stem cells in an inflammatory microenvironment. Frontiers in Immunology, 14, 1074863. https://doi.org/10.3389/fimmu.2023.1074863
28. Majumdar, M. K., Thiede, M. A., Haynesworth, S. E., Bruder, S. P., & Gerson, S. L. (2000). Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. Journal of Hematotherapy & Stem Cell Research, 9(6), 841–848. https://doi.org/10.1089/152581600750062264
29. Hemeda, H., Jakob, M., Ludwig, A.-K., Giebel, B., Lang, S., & Brandau, S. (2010). Interferon-γ and tumor necrosis factor-α differentially affect cytokine expression and migration properties of mesenchymal stem cells. Stem Cells and Development, 19(5), 693–706. https://doi.org/10.1089/scd.2009.0365
30. González-González, A., García-Sánchez, D., Dotta, M., Rodríguez-Rey, J. C., & Pérez-Campo, F. M. (2020). Mesenchymal stem cells secretome: The cornerstone of cell-free regenerative medicine. World Journal of Stem Cells, 12(12), 1529–1552. https://doi.org/10.4252/wjsc.v12.i12.1529
31. Kehl, D., Generali, M., Mallone, A., Heller, M., Uldry, A.-C., Cheng, P., Gantenbein, B., Hoerstrup, S. P., & Weber, B. (2019). Proteomic analysis of human mesenchymal stromal cell secretomes: a systematic comparison of the angiogenic potential. npj Regenerative Medicine, 4(1), 8. https://doi.org/10.1038/s41536-019-0070-y
32. Hsiao, S. T.-F., Asgari, A., Lokmic, Z., Sinclair, R., Dusting, G. J., Lim, S. Y., & Dilley, R. J. (2012). Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue. Stem Cells and Development, 21(12), 2189–2203. https://doi.org/10.1089/scd.2011.0674
